Except for the historical information contained herein, this press release
contains forward-looking statements within the meaning of Section 21E of the
Securities and Exchange Act of 1934, as amended that involve a number of risks
and uncertainties. These forward-looking statements may be identified by
reference to a future period by use of forward-looking terminology such as
"expect," "anticipate," "could," "would," "will," and "may" and other words of
similar nature. There are certain important factors and risks that could cause
results to differ materially from those anticipated by the statements herein.
Such factors and risks include the successful completion of aforementioned
acquisitions and ongoing developments of the core business model, the business
conditions and growth in related areas of biometric and biometric security,
and in the economy in general. Competitive factors include the rapid pace of
alternative technology advancements and the Company's ability to gain market
acceptance of its evolving products. Other risks may be detailed from time to
time in our filings with the Securities and Exchange Commission. Neither
DICUT, INC. nor its subsidiaries undertake any obligation to update or revise
any forward- looking statements, whether as a result of new information,
future events or otherwise.

For Further information about this release and the business at DICUT,
INC., contact: Pierr Quilliam of DICUT, INC., +1-770-795-9955, fax:
+1-770-795-9222, quilliam@dicutinc.com; or Rich Kaiser of YES INTERNATIONAL,
+1-800-631-8127, for DICUT, INC.

SOURCE DICUT, INC.
-0- 01/20/2004
/CONTACT: Pierr Quilliam of DICUT, INC., +1-770-795-9955, fax:
+1-770-795-9222, quilliam@dicutinc.com; or Rich Kaiser of YES INTERNATIONAL,
+1-800-631-8127, for DICUT, INC./
(DCUT)

CO: DICUT, INC.
ST: Georgia
IN: HTS CPR OTC BIO
SU:

quote:

---

Originally posted by dardadog:
MARIETTA, Ga., Jan. 20 /PRNewswire-FirstCall/ -- DICUT, INC.
(OTC Bulletin Board: DCUT) an advanced security solutions provider, today
announced details of a new, refocused corporate strategy to move the Company
forward through 2004. Having spent the last 30-days fine tuning the corporate
business plan and forward strategy, DICUT'S CEO, Raj Kalra, has released
details of how and where the Company will be focusing, its efforts. DUCUT's
two main areas of focus will involve its unique ACS Multimodal biometric
product line and the acquisition strategy to augment the Company's existing
security offering.
The ACS Multimodal product is a complete access control system utilizing
innovative dual biometric security. DICUT's Aurora Biosecurity Solutions
division is targeting the government and commercial sectors for integration of
the ACS Multimodal product-line.
The focus in the government sector will consist of passport and border
control as well as Public building security. The commercial sector focus
includes building and office security, visitor passes and event security.
Market estimates predict total spending on access control will grow to $3.3
billion next year. Of that, $600 million will be spent on biometric and
biometric security. The Government has earmarked $20 million for biometric,
small business set-asides.
To augment the existing ACS Multimodal security line, DICUT is actively
seeking acquisition targets and opportunities. The newly implemented
acquisition strategy will focus on merger or acquisition opportunities that
represent the potential to generate positive cash flow and profitable
operations for the Company. Acquisition targets will include companies with
revenue greater than $5 million dollars per annum as well as a positive EBITA.
To date, the Company has identified several potential acquisition targets and
has commenced negotiations.
"2003 was an exciting year for DICUT, INC.," said Raj Kalra, Chairman and
CEO. "With our acquisition of Aurora Biometrics and the introduction of the
ACS Multimodal security line, we are poised to deliver an innovative security
solution to both the public and private sectors resulting in positive cash
flow and strong financial performance for our shareholders. I felt, however,
that we needed to take a step back and refocus our efforts in order to deliver
those results. With the new corporate strategy in place, I am confident that
the Aurora Biosecurity division will be successful in taking our innovative
security solutions to market and we will be able to acquire a company that
compliments our current product offering and help deliver to the bottom-line.

Except for the historical information contained herein, this press release
contains forward-looking statements within the meaning of Section 21E of the
Securities and Exchange Act of 1934, as amended that involve a number of risks
and uncertainties. These forward-looking statements may be identified by
reference to a future period by use of forward-looking terminology such as
"expect," "anticipate," "could," "would," "will," and "may" and other words of
similar nature. There are certain important factors and risks that could cause
results to differ materially from those anticipated by the statements herein.
Such factors and risks include the successful completion of aforementioned
acquisitions and ongoing developments of the core business model, the business
conditions and growth in related areas of biometric and biometric security,
and in the economy in general. Competitive factors include the rapid pace of
alternative technology advancements and the Company's ability to gain market
acceptance of its evolving products. Other risks may be detailed from time to
time in our filings with the Securities and Exchange Commission. Neither
DICUT, INC. nor its subsidiaries undertake any obligation to update or revise
any forward- looking statements, whether as a result of new information,
future events or otherwise.

For Further information about this release and the business at DICUT,
INC., contact: Pierr Quilliam of DICUT, INC., +1-770-795-9955, fax:
+1-770-795-9222, quilliam@dicutinc.com; or Rich Kaiser of YES INTERNATIONAL,
+1-800-631-8127, for DICUT, INC.

SOURCE DICUT, INC.
-0- 01/20/2004
/CONTACT: Pierr Quilliam of DICUT, INC., +1-770-795-9955, fax:
+1-770-795-9222, quilliam@dicutinc.com; or Rich Kaiser of YES INTERNATIONAL,
+1-800-631-8127, for DICUT, INC./
(DCUT)

CO: DICUT, INC.
ST: Georgia
IN: HTS CPR OTC BIO
SU:

---